Eli Lilly and Company Enters $2.3 Billion Agreement to Acquire Ajax Therapeutics - The Healthcare Technology Report.

Eli Lilly and Company Enters $2.3 Billion Agreement to Acquire Ajax Therapeutics The Healthcare Technology Report.